These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Michel JB; Heudes D; Michel O; Poitevin P; Philippe M; Scalbert E; Corman B; Levy BI Am J Physiol; 1994 Jul; 267(1 Pt 2):R124-35. PubMed ID: 8048614 [TBL] [Abstract][Full Text] [Related]
30. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats. Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672 [TBL] [Abstract][Full Text] [Related]
31. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition. Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253 [TBL] [Abstract][Full Text] [Related]
32. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade. Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346 [TBL] [Abstract][Full Text] [Related]
33. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes. Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action. Cao Z; Hulthén UL; Allen TJ; Cooper ME J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919 [TBL] [Abstract][Full Text] [Related]
35. Nebivolol treatment improves resistant arterial function and reduces ventricular hypertrophy and angiotensin II in spontaneously hypertension rats. Wang Y; Zhang MS; Liu Y J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):146-55. PubMed ID: 23263161 [TBL] [Abstract][Full Text] [Related]
36. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition. Thuillez C; Mulder P; Elfertak L; Blaysat G; Compagnon P; Henry JP; Richard V; Scalbert E; Desche P Am J Hypertens; 1995 May; 8(5 Pt 2):7S-12S. PubMed ID: 7646844 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of supplementation with whey mineral and potassium on arterial tone in experimental hypertension. Wu X; Tolvanen JP; Hutri-Kähönen N; Kähönen M; Mäkynen H; Korpela R; Ruskoaho H; Karjala K; Pörsti I Cardiovasc Res; 1998 Nov; 40(2):364-74. PubMed ID: 9893730 [TBL] [Abstract][Full Text] [Related]